Catalyst Wire Dossier Catalyst Wire Dossier

Levetiracetam (L059)

levetiracetam · UCB Pharma
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Levetiracetam (L059), covering 2013-09-17 to 2013-09-17. Get the full timeline:

Most recent: Clinical Trial Update: Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind Method [Phase 2]

See pricing